BioInvent International | Evaluate

December 23, 2016

Snippet roundup: Biogen's chief exec choice underwhelms as a big 2016 decision is delayed to 2017

November 09, 2016

No way to bury Arrowhead and Bioinvent’s bad news

April 14, 2015

On to the curious for Thrombogenics

July 16, 2013

Early-stage asset risk no deterent to partnering deals

March 22, 2013

Genmab basks in Nordic glory

January 09, 2013

Sarepta joins the big league as best-performing 2012 share

October 10, 2012

Wockardt and Arena lead small-cap gainers through nine months

August 17, 2012

Therapeutic Focus – Avastin provides glimmer in glioblastoma but progress still slow

July 11, 2012

BioInvent scores unpleasant biotech triple

July 09, 2012

Event - FDA adcom should provide clear vision of ThromboGenics's future

May 07, 2010

Thrombo, Bioinvent clot buster shows promise but deal may prove elusive

Load More